the battle against tobacco, cancer and heart disease · cancer and heart disease the adoption of...
TRANSCRIPT
The Battle Against Tobacco,
Cancer and Heart Disease
The adoption of the Tobacco Products Directive
19th
Summary of the meeting
Mr Busoi MEP (Chair of the MEP
opened the meeting. Mr Busoi stressed that in the European Union, cancer and cardiovascular
diseases (CVD) account for 65% of mortality.
major risk factor for these diseases; it is in fact the most important modifiable risk factor. 16% of
deaths from CVD in men and 5% of deaths in women, in the European Union, are due to smoking. A
higher proportion of premature deaths from CVD are due to smoking: in the age group 35
smoking causes 28% of CVD deaths in men and 13% in women.
Mr Peterle stressed the importance of prevention, especially in view of the shocking figures about
girls smoking, and the rise this gives in lu
across eight European and Scandinavian countries, 270,000 people are diagnosed every year with
cancers caused by smoking. Smoking is known to be a major contributor to a variet
including lung, colon and bladder cancers. In addition, current smokers are 2.6 times as likely as
never smokers to develop a tobacco
Tobacco use is the most important risk factor for c
71% of global lung cancer deaths. Deaths from cancer worldwide are projected to continue rising,
with an estimated 13.1 million deaths in 2030.
Florence Berteletti Kemp, Director of the
Commission’s proposal. She highlighted that the main
standardised packaging and pictorial warnings
showed a video demonstrating t
importance of not allowing the package to be a marketing tool that makes cigarette attractive for
children and young people but rather to present stark information about the c
1 Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and
Nutrition Study, 2012 2 International Agency for Research on Cancer, 2012
The Battle Against Tobacco,
er and Heart Disease
The adoption of the Tobacco Products Directive
th February 12:30h to 14:15h
Mr Busoi MEP (Chair of the MEP Heart Group, ALDE, Rom) and Mr Peterle (Chair of MAC
Mr Busoi stressed that in the European Union, cancer and cardiovascular
diseases (CVD) account for 65% of mortality. CVD accounts for 40% and cancer for 26%. Tobacco is a
major risk factor for these diseases; it is in fact the most important modifiable risk factor. 16% of
deaths from CVD in men and 5% of deaths in women, in the European Union, are due to smoking. A
on of premature deaths from CVD are due to smoking: in the age group 35
smoking causes 28% of CVD deaths in men and 13% in women.
stressed the importance of prevention, especially in view of the shocking figures about
and the rise this gives in lung cancer among women. A recent study showed that
across eight European and Scandinavian countries, 270,000 people are diagnosed every year with
cancers caused by smoking. Smoking is known to be a major contributor to a variet
including lung, colon and bladder cancers. In addition, current smokers are 2.6 times as likely as
never smokers to develop a tobacco-related cancer and ex-smokers have 1.5 times the risk.
Tobacco use is the most important risk factor for cancer causing 22% of global cancer deaths and
71% of global lung cancer deaths. Deaths from cancer worldwide are projected to continue rising,
with an estimated 13.1 million deaths in 2030.2
Kemp, Director of the Smoke Free Partnership presented the challenges of the
She highlighted that the main priority for the public health community is
pictorial warnings covering 80% of the front and back of
demonstrating that children find cigarette packs attractive and underlining the
importance of not allowing the package to be a marketing tool that makes cigarette attractive for
children and young people but rather to present stark information about the consequences of
Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and
International Agency for Research on Cancer, 2012
The Battle Against Tobacco,
er and Heart Disease
The adoption of the Tobacco Products Directive
(Chair of MAC, EPP, Sl)
Mr Busoi stressed that in the European Union, cancer and cardiovascular
for 40% and cancer for 26%. Tobacco is a
major risk factor for these diseases; it is in fact the most important modifiable risk factor. 16% of
deaths from CVD in men and 5% of deaths in women, in the European Union, are due to smoking. A
on of premature deaths from CVD are due to smoking: in the age group 35-69 years,
stressed the importance of prevention, especially in view of the shocking figures about
A recent study showed that
across eight European and Scandinavian countries, 270,000 people are diagnosed every year with
cancers caused by smoking. Smoking is known to be a major contributor to a variety of cancers,
including lung, colon and bladder cancers. In addition, current smokers are 2.6 times as likely as
smokers have 1.5 times the risk.1
ancer causing 22% of global cancer deaths and
71% of global lung cancer deaths. Deaths from cancer worldwide are projected to continue rising,
the challenges of the
y for the public health community is
front and back of pack. She
underlining the
importance of not allowing the package to be a marketing tool that makes cigarette attractive for
onsequences of
Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and
smoking that will deter uptake of smoking.
http://www.youtube.com/watch?v=c_z
Other challenges with regard to
• Ingredients, flavourings and additives. Prohibition of certain flavourings and additives is
mentioned in the proposal, but it does not go
• Not including a ban on display of cigarette packs
Mr Tonio Borg, EU Commissioner fo
the main aim of the proposal is to prevent youngsters from picking up the habit of smoking.
The overall objective is to reduce the number
smoking”, the Commissioner said,
must look like tobacco and must taste like tobacco.”
health is a strong value in itself and i
unlikely to have net negative econ
tobacco would be spent in other sectors
The Commissioner emphasised that pictor
making it clear that using this product will damage their health.
As to Snus and smokeless tobacco, Commissioner Borg mentioned that people believe that when
there is no smoke, there is no harm.
harmful. The ban on Snus will remain
Snus but in exchange must comply with its obligation
European countries.
Some additives will be allowed, but not if they fall into the category of
Rapporteur Linda McAvan (MEP, S&D, UK)
prevent young people from starting smoking
people are going up now and take adequate measures to help
agreeing with Commissioners Borg that tobacco should look and taste like tobacco, not something
you want to be seen with.
Eugene Lennon, Health Permanent
2013 until 30 June 2013) mentioned that for Ireland, the focus would be on standardised packaging,
tobacco as a public health issue, the prohibi
informal Health Council in March 2013, Ireland will put the issue of smoke
agenda. Ireland was pleased to see the Commission adopted the proposal at the end of 2012 (as
promised) and intends to move this dossier forward quickly.
During the Question and answer session
will; Snus and other ingredients, e
that free will is not an issue: the new proposal does not prohibit
attractive for young people to start. He also said that
smoking-related diseases: the revenue of tobacco is less than the bill the state
care of people suffering from tobacco related
smoking that will deter uptake of smoking. The video can be downloaded here:
http://www.youtube.com/watch?v=c_z-4S8iicc
the proposal are:
ngredients, flavourings and additives. Prohibition of certain flavourings and additives is
mentioned in the proposal, but it does not go far enough.
an on display of cigarette packs at points of sale.
Commissioner for Health and Consumer Protection, informed the audience that
to prevent youngsters from picking up the habit of smoking.
The overall objective is to reduce the number of smokers by 2% over 5 years. “We don’t prohibit
said, “we make it less attractive to the young. That is why tobacco
must look like tobacco and must taste like tobacco.” The Commissioner also stressed the fact that
and it also has an economic value. He stressed that
economic consequences not least because money not spend on
in other sectors.
that pictorial warnings will help people take informed decisions by
that using this product will damage their health.
and smokeless tobacco, Commissioner Borg mentioned that people believe that when
there is no smoke, there is no harm. But, the Commissioner pointed out smokeless tobacco is also
will remain in place: Sweden will be allowed to keep it is concession to sell
must comply with its obligation not to bring Snus on the market in other
additives will be allowed, but not if they fall into the category of characterising flavours
Rapporteur Linda McAvan (MEP, S&D, UK) spoke out in support of the proposal, because it will help
from starting smoking. “We have to look at why the smoking trends in young
people are going up now and take adequate measures to help them not take up the
with Commissioners Borg that tobacco should look and taste like tobacco, not something
ermanent Representative for Ireland (Council Presidency from 1 Janu
il 30 June 2013) mentioned that for Ireland, the focus would be on standardised packaging,
tobacco as a public health issue, the prohibition of slim cigarettes. He also mentioned that at the
informal Health Council in March 2013, Ireland will put the issue of smoke free environments on the
agenda. Ireland was pleased to see the Commission adopted the proposal at the end of 2012 (as
ed) and intends to move this dossier forward quickly.
Question and answer session, the Commissioner answered questions on smoker’s free
and other ingredients, e-cigarettes and marketing of tobacco. Commissioner Borg stated
that free will is not an issue: the new proposal does not prohibit smoking; it just makes it less
attractive for young people to start. He also said that it is important to consider who pays the bill for
he revenue of tobacco is less than the bill the state has to pay for taking
obacco related diseases. He also indicated that Snus
ngredients, flavourings and additives. Prohibition of certain flavourings and additives is
informed the audience that
to prevent youngsters from picking up the habit of smoking.
“We don’t prohibit
we make it less attractive to the young. That is why tobacco
The Commissioner also stressed the fact that
also has an economic value. He stressed that the Directive is
not spend on
people take informed decisions by
and smokeless tobacco, Commissioner Borg mentioned that people believe that when
mokeless tobacco is also
Sweden will be allowed to keep it is concession to sell
on the market in other
characterising flavours.
, because it will help
We have to look at why the smoking trends in young
them not take up the habit.” She said
with Commissioners Borg that tobacco should look and taste like tobacco, not something
(Council Presidency from 1 January
il 30 June 2013) mentioned that for Ireland, the focus would be on standardised packaging,
tion of slim cigarettes. He also mentioned that at the
free environments on the
agenda. Ireland was pleased to see the Commission adopted the proposal at the end of 2012 (as
the Commissioner answered questions on smoker’s free
Commissioner Borg stated
it just makes it less
who pays the bill for
has to pay for taking
Snus is but a small
part of the Directive. Member States had forbidden
Commission sticks to status quo in the current proposal.
Commission has tried to make tobacco look and taste like tobacco, in an attempt to present it
(market it) in a way which does not make it more attr
In her concluding remarks, Nessa Childers MEP
stressed the importance of policy makers in the EP to work together with the rapporteur to protect
EU citizen’s health from tobacco
Tobacco Cessation organised by the MAC group in the European Parliament.
part of the Directive. Member States had forbidden Snus when Sweden entered the
Commission sticks to status quo in the current proposal. He further stressed the fact that the
Commission has tried to make tobacco look and taste like tobacco, in an attempt to present it
(market it) in a way which does not make it more attractive to young people.
Nessa Childers MEP, Vice President of the MAC group
stressed the importance of policy makers in the EP to work together with the rapporteur to protect
EU citizen’s health from tobacco use. She invited all participants to come to the Exhibition on
Tobacco Cessation organised by the MAC group in the European Parliament.
when Sweden entered the EU, and the
stressed the fact that the
Commission has tried to make tobacco look and taste like tobacco, in an attempt to present it
, Vice President of the MAC group (S&D, Ireland)
stressed the importance of policy makers in the EP to work together with the rapporteur to protect
She invited all participants to come to the Exhibition on
REPORT
Calling Time on Europe's Alcohol Problem
Using pricing policies to protect public health in Europe
-
A challenge for democracy
Co-hosted by Rebecca Taylor MEP (UK, ALDE)
Alyn Smith MEP (UK, Greens/EFA), Antonyia Parvanova MEP (Bulgaria, ALDE) and Catherine
Stihler MEP (UK, S&D)
European Parliament (Brussels)
24 April 2013, 16.45 – 20.00
Background information
The current EU framework in the area of alcohol - the EU Strategy to support Member States in
reducing alcohol related harm - came to an end in 2012 but Europe still remains the world heaviest
drinker. Over recent months, EU countries have been witnessing an increasing trend in applying
pricing measures to unhealthy products in order to discourage their consumption, in particular by at-
risk groups, most notably the proposal to introduce Minimum Unit Pricing (MUP) in Scotland.
The public health evidence as well as the social and health gains of raising alcohol price and thus
availability are unequivocal and indisputable, although they differ depending on the measure used.
The power of democratically elected governments to introduce such measures is however
threatened by the tactics of the alcohol industry. Lobbying and legal challenges are threatening to
slow down or derail electoral promises and economic and social gains in reducing alcohol harm.
Concerned by such an influence and the pressing need to protect Europe’s population from alcohol
abuse, the European Public Health Alliance (EPHA) and the Royal College of Physicians (RCP London),
supported by Eurocare gathered the public health community, Members of the European Parliament
and representatives from Member States to exchange on the way forward. In the current economic
climate more than ever, it is crucial that governments demonstrate their commitment to policy
making that supports a healthy and productive population, challenge the groundless arguments used
by economic operators, take action against preventable health threats and their associated costs and
do not hinder policy efforts to prioritise public health over economic interests.
Welcome and opening remarks
Rebecca Taylor, Member of the European Parliament
Rebecca Taylor MEP (ALDE, UK) welcomed participants to the seminar emphasising the timeliness of
the discussions as the Scottish Parliament passed the Minimum Pricing of Alcohol Bill a year ago
almost day by day, a scheme that should have come to force this month. At the time of the seminar,
the United Kingdom was also considering MUP although no proposals had yet been made. Given that
the European Union's Alcohol Strategy was due to be evaluated during 2013. Ms Taylor MEP shared
with the audience a question she had tabled with Ms Parvanova MEP asking the Commission
whether the Strategy would be reviewed.
Before introducing all speakers, Ms Taylor MEP pointed out the importance of having a Commission
representative attending the seminar that did not only focus on alcohol pricing policies, but did go
broader, tackling alcohol misuse and public health, including the influence of economic operators on
alcohol policy and the decision-making process.
Antonyia Parvanova, Member of the European Parliament
Ms Antonyia Parvanova MEP (ALDE, BU) followed on from her collegue Ms Taylor MEP. She stressed
the influence of economic operators on policies and in particular the production and use of
independent versus industry funded research to justify policies. While reminding participants about
the harmful use of alcohol and its social and health consequences, she emphasised the need to
protect young people in particular.
“Is the drinks industry damaging democracy as well as health?”
Nick Sheron, Royal College of Physicians Representative to the EU Alcohol and Health Forum
As a professional hepatologist, Nick Sheron began his presentation by sharing some of his
observations: liver deaths increased steadily over the past years, the majority of which being alcohol
related. Liver diseases have not only changed in terms of frequency, their nature has also changed.
While it used to be a disease of the rich, it increasingly has become a disease of deprivation. Dr
Sheron emphasised the relation between alcoholic beverages’ prices and consumption, comparing
the effects of taxation and minimum unit pricing. When mentioning the Scottish MUP scheme he
explained that the measure was part of the Scottish Nationalist Party Manifesto and that, as a rule, it
was forbidden to oppose the Manifesto once voted on. Thus, he highlighted that the current debates
were actually profoundly anti-democratic.
Responding to the alcohol industry data according to which MUP only affected poor people, Dr
Sheron demonstrated visually his data according to which the scheme had the most impact on
hazardous and even more on harmful and/or dependant drinkers. Nick Sheron concluded his
intervention by reiterating that MUP as a measure that would exquisitely target heavy consumers
and that alcohol industry main concern was to lose their profitability.
“Minimum alcohol price policies in action: the Canadian experience”
Tim Stockwell, Centre for Addictions Research of British Columbia, University of Victoria
Dr Tim Stockwell began his presentation by introducing and thanking his research team with whom
he produced the data he was about to present. Sharing the Canadian experience of minimum alcohol
price policies, Dr Stockwell informed participants that the measure was implemented in 8 regions of
Canada and in some of them for more than 40 years. This made Canada one of the 6 countries
worldwide where minimum unit pricing is being implemented (others were Russia, Ukraine, the
United States (5 States), Moldova and Uzbekistan). Dr Stockwell presented, according to their
effectiveness, different pricing measures that could be implemented to alcoholic beverages: ban on
below-cost alcohol being the least effective, minimum profit margin, minimum retail price per litre of
beverage, minimum price per unit of alcohol being the most effective measure. He then shared the
scientific evidence behind alcohol price and tax strategies, i.e a 10% price increase led to an average
5% reduced consumption, together with reduced hazardous drinking levels and reduced alcohol-
related injuries and illnesses.
To the question “Do increases in the minimum alcohol prices lead to reduced consumption?” Dr
Stockwell responded through two illustrative case studies: British Columbia and Saskatchewan. To
the question linking alcohol MUP and reduced related harm, he responded that a 10% increase in
minimum prices was associated with a 32% decrease in wholly alcohol caused deaths. Tim Stockwell
concluded his intervention by deconstructing, one by one, each of the alcohol industry criticisms he
was confronted to and by emphasizing that alcohol MUP was the most effective way to go.
“Ministerial perspective”
Alex Neil, Scottish Cabinet Secretary for Health and Wellbeing
The Scottish Cabinet Secretary for Health and Wellbeing Alex Neil thanked the previous speakers and
declared that in light of this evidence, it is profoundly clear the Scottish minimum unit pricing
measure is the right thing to do. Illustrating the alcohol-related situation in Scotland over recent
years, with an average 11 liters of pure alcohol consumed per adult every year and the associated
health consequences, Mr. Neil insisted that the scale of the problem required a meaningful and
effective government response. Changing Scotland’s relationship with alcohol has to be a priority.
Responding to some critics of the scheme, Mr Neil explained that alcoholic beverages’ affordability
increased considerably (by 45%) over recent years, especially in supermarkets.
Mr Neil presented the Scottish Court case, explaining that MUP would not be implemented before a
final Court decision is taken. He also explained the evidence behind the 50p proposal and briefly
responded to the Commission opinion, which demonstrated a preference for taxation, explaining
that taxation alone would not achieve what MUP could achieve.
The newly released London School of Hygiene & Tropical Medicine study was mentioned during the
discussions for the evidence it brought on the misleading arguments and information manipulation
deliberately used by the Scottish industry in the context of the consultation ran in 2008. The Scottish
Cabinet Secretary concluded his intervention by reminding the room that, with a built-in sunset
clause, if in 5 years time, the implementation of the scheme does not reach the expected outcomes,
the measure would be removed.
Roundtable discussions
Monika Kosińska, EPHA’s Secretary General chaired the roundtable discussions. She announced that
a slight change would occur in the agenda as a representative from the European Commission was
able to join the debate. She opened the discussion to the floor.
Peter Rice, Chair of the Scottish Health Action on Alcohol Problems (SHAAP) emphasised in his
intervention how untrue the arguments used by economic operators were and echoed some of the
facts and figures mentioned by Alex Neil illustrating the landscape in which alcohol policies have to
be considered (bigger bottles, increased deaths, etc.) in Scotland.
Tiziana Codenotti, Chair of the European Alcohol Policy Alliance (Eurocare) asked Mr Neil whether
MUP would apply differently on imported drinks, to which he responded that the measure would
apply to all alcoholic beverages sold in Scotland, regardless of origin and that current assessments
indicate that the majority of drinks affected originate in fact in Scotland.
Rebecca Taylor MEP (UK, ALDE) asked whether the measure would have an impact on the cross-
border sales between Scotland and the United Kingdom.
Monika Kosinska (EPHA) welcomed then the participation of Despina Spanou, European Commission
Director for Consumer Policy who began her intervention by reminding the audience the scope of the
day discussions: as far as the EU treaties are concerned, the internal market rules were stronger than
the public health ones. Ms Spanou briefly mentioned some of the results of the evaluation of the
current EU framework in the area of alcohol policy, i.e the European strategy to reduce alcohol-
related harm, reassuring the added value of EU action even though in her experience with the
Alcohol Strategy, five years were not enough.
Before passing the floor to Franco Sassi, Monika Kosinska re-emphasised the dichotomy between the
single market in the interests of economic operators versus in the public health interest.
“Response in light of a forthcoming OECD report on alcohol consumption”
Dr Franco Sassi, Organisation for Economic Co-operation and Development (OECD)
Franco Sassi shared some of the pressure felt by his organisation whilst conducting alcohol research,
pressure from both the industry and the non-governmental organisations. While both stakeholders
would prefer the OECD to focus its work on their specific areas of concerns, Dr Sassi highlighted that
multiple interventions in a broad range of domains was preferable according the evidence available.
He also pointed out that targeted actions were key, especially to target the most vulnerable groups,
which goes at odds to population approach.
“Response from the perspective of a medical practitioner working with the homeless community”
Henrik Thiesen, European Federation of National Organisations Working with the Homeless
(FEANTSA)
Henrik Thiesen shared his experience as a medical doctor working with homeless people in Denmark,
a majority of which were migrants from Central and Eastern Europe. Dr Thiesen pointed out that,
beyond the wide spread of cirrhosis, homeless people using alcoholic beverages experienced
increased levels of mortality. Dr Thiesen also emphasised how access to housing and healthcare
services was important as part of harm reduction approaches.
A number of Member States representatives were present in the room and were offered with the
opportunity to intervene and share their national experience and/or perspective on the issue.
Ariane Amberg representing the Permanent Representation of Switzerland to the European Union
informed participants that in March 2013, the lower chamber of the Swiss Parliament voted in favour
of alcohol MUP as part of a broader alcohol policy and that the second chamber opinion was
expected in the coming months. She also mentioned that the bilateral trade agreement Switzerland
had with the EU has been raised in some quarters as a potential obstacle to the adoption of alcohol
MUP.
Mathieu Capouet, representing the Belgium Ministry for Health mentioned that Belgium was in the
process of drafting a new alcohol plan therefore thanked the organisers and stressed he was
carefully listened to the discussions, which were very useful. He explained that Belgium hope to have
the new plan by the end of 2013.
Peter Hartog, representing the Dutch Ministry for Health said that he was very interested in the
discussions related to minimum unit pricing. He emphasised the misinformation that was
surrounding the issue and echoed the discussions related to the balance between economic/financial
interests and public health interests.
“Response in relation to alcohol lobbying and transparency”
Olivier Hoedeman, Corporate Europe Observatory
Oliver Hoedeman brought a new topic into to the debate: the issue of lobbying and transparency in
the area of alcohol policy. While the European Transparency Register was presented as a good tool
to reduce the influence of specific interests on policies, Mr Hoedeman explained that place was left
for improvement notably due to the fact that it remained voluntary. A review of the Register was
expected for June which presents an opportunity to improve the tool. Through his intervention, Mr
Hoedeman insisted on the importance of holding policy makers accountable for their actions and
thus requested more transparency from the European Commission as well as the European
Parliament when meeting with industry lobbyists. According to him, while the 2011 European
Parliament Code of Conduct was a first step in the right direction the text was poorly enforced which
threatened its efficiency.
“Response in relation to the public debate in Scotland”
Evelyn Gillan, Alcohol Focus Scotland
Evelyn Gillan concluded the round of interventions by sharing her experience as a leader of an
organisation directly involved in the Scottish Court case. In order to illustrate the massive powerful
vested interests operating in Scotland, she told participants that following on from the first
discussions on MUP and lack of Parliamentary adoption, the alcohol industry sent each member of
the Scottish Parliament a crate of beer. She concluded her intervention by reminding the room how
crucial coalitions were as well as good quality data and that public health interests should be put
ahead of industry interests.
“Concluding remarks”
Catherine Stihler MEP (UK, S&D) concluded the seminar discussions by pointing out that the evidence
on minimum unit pricing was overwhelming, that it was crucial to continue sharing best practices and
available evidence and that in order to advance alcohol policies a real political leadership was
needed.
Alyn Smith MEP (UK, Greens/EFA) expressed that support from different political groups was needed
in order to go ahead with such policies. More generally he welcomed meetings like this as it offered
opportunities to exchange best practices.
[Seminar report] Can EU Citizens Afford TheirMedicines?
A event on the Economic Crisis & Access to Medicines In Europe -16 May, 9:00–18.00 European Parliament (Brussels) Room Jan4Q2
This high level meeting revolved around various politicalprocesses linked to the economic crisis. Some of the topics discussed include implementation ofthe Europe 2020 strategy, as well as pharmaceutical legislation for ensuring that people living inEurope have access to a wide range of quality and affordable medicines.
The meeting hosted by Mr Alejandro Cercas, MEP (Spain,S&D) and by the Socialists and Democrats in theEuropean Parliament (S&D Group) served to assess the impact of cost-containment policies put in placein some EU member states. Participants debated which role new innovation models and instruments couldplay in ensuring the affordability of medicines.
The seminar brought together actors and institutions that do not traditionally meet or exchangeideas. The event put forward a set of recommendations on how multilateral institutions, ministries of finance,research and health can join forces to prevent that the current crisis on access to medicaments spirals out ofcontrol.
There are many ways in which you can learn about the main issues discussed in this seminar:
Watch the seminar recorded
Retreieve the Tweeter conversation at the conferece’s Twitter hashtag #access2medicinesEU
Read the conference’s press statement - Access to medicines in Europe: The EU cannot save banks whilesacrificing people’s health
Download the SPEAKERS’ PRESENTATIONS (pdf files):
David Hammerstein (Trans-Atlantic Consumer Dialogue -TACD)- The 10 key words on access to medicine inthe EU.Aida Batista (European Association of Hospital Pharmacists) - On the frontline of access to medicines inEurope.John Chave (Secretary General of the Pharmaceutical Group of the EU) - Medicine Shortages.Jose Manuel Silva (President of the Portuguese Medical Association) - Economic Crisis: Access to Medicinesin EuropeNicky Voudouri (Medical Coordinator, PRAKSIS) - Access to Health the Greek situation.Christine Leopold (Austrian Health Institute - WHO Collaborating Centre for Pharmaceutical Pricing andReimbursement Information) - Pharmaceutical policy measures implemented in response to the recession inEurope (2012-2013)Els Torreele (Director, Access to Essential Medicines Initiative Open Society Foundations) - Public interestdriven drug development is possible cost effective and leads to affordable medicines.Hugo Hurts (Director Department of Pharmaceutical Affairs and Medical Technology, Ministry of Health,Welfare and Sport - The Netherlands) - Cost Containment. Measures in the NetherlandsJames Love (Knowledge Ecology International) - Delinkage.The Economic Crisis and Access to Medicines inEurope.Joan Rovira (Department of Economic Theory, University of Barcelona) - Can EU citizens afford theirmedicines?.Lieven Annemans (Department of Health Economics at Ghent University and Brussels University) - What canbe done to increase equity in access to valuable medicines.Michel Goldman (Executive Director from the Innovative Medicines Initiative) - The Innovative MedicinesInitiative.Teresa Alves (La Revue Prescrire) - Innovation: a reality check.
To know more about the topic of access to medicines in the context of the economic crisis, read EPHAbriefing on access to medicines in Times of Austerity
Related documents
[Joint Press Statement]Access to medicines inEurope: The EU cannotsave banks whilesacrificing people’shealth
Revised EPHA positionon clinical trials
*Updated* EPHAbriefing on AntimicrobialResistance
About us
Library and Media Centre
EPHA consultancy -Public relations, mediaand events: benefit fromEPHA expertise!
EPHA 4th AnnualConference. Brave NewWorld: 4-5 September2013
EPHA meeting room forrent
Thinking of joiningEPHA?
Credits
The European Public HealthAlliance runs projects whichreceive financial supportfrom the EuropeanCommission. The viewsexpressed in this website donot necessarily reflect theofficial views of the EUinstitutions.
This website is powered byopen source solutions andruns on a Linux server.
A A¯̄
FollowFollow 1,941 followers
Newsletter
RSS
Members only
search >>
Other articles you might find interestingabout Access to Medicines
Open letter on trilogue negotiations on EU’s Framework Programme for Research and Innovation (2014-2020) Horizon 2020
66th World Health Assembly approves Mental Health Action Plan 2013-2020
about Pharmaceuticals and MedicinesReindustrialising Europe to promote competitiveness and sustainability - But does it promote health?
EPHA co-signs open letter on Antimicrobial Resistance (AMR) to EU Commissioner for Health andConsumers
about Health Rights and PatientsMedical Devices proposal: more than 1,000 amendments to be discussed
[Joint Press Statement] Access to medicines in Europe: The EU cannot save banks while sacrificingpeople’s health
about ResearchWHO consultation on climate change and health research priorities (July 19th)
[EPHA Briefing] Access to Medicines in Europe in Times of Austerity
about TransparencyClinical trials: Exploring the limits of transparency
EP resolution underlines the need for action on medicines access problem
about Information to PatientsThe European Medicines Agency (EMA) publishes list of drugs under additional monitoring
The Lancet to launch Europe series on determinants of population health and effects of health policy
Last modified on June 6 2013.
0
European Public Health Alliance - Rue de Trèves 49-51 Box 6, B-1040 Brussels, Belgium . phone: +32 2 230 3056 - fax: +32 2 233 3880 - [email protected]
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 1/11
Access to medicines crisis in Greece: Society demands fair solutions
European Parliament office in Athens, 13 December 2013
Event summary report
Conference Overview
130 people showed for the event from all sectors (news agencies, medical associations, doctors’
associations, patients’ associations, pharmacists and numerous representatives of the
pharmaceutical industry). The conference was attended by the parliamentary representative of the
leading opposition party SYRIZA Mr. Panayiotis Kouroumplis. European Commission’s Task Force for
Greece (TFGR) was represented by Ms Giulia Del Brenna who flew from Brussels. Moreover,
presentations were given by the author of the latest law on medicines in Greece Mr. Maniadakis and
from Mr. Charalambos Karathanos, pharmacist and close advisor to the Minister of Health Mr. Adonis
Georgiadis.
Médecins Sans Frontières (MSF), Médecins du Monde (MdM Greece), PRAKSIS NGO, Greece’s
leading consumer association and TACD member EKPIZO, the Greek cancer patients’ association
DEDIDIKA, MEP Nikos Chrysogelos (Greens/EFA, EL) and the European Public Health Alliance (EPHA)
all actively supported and promoted the event.
About 50 patients’ representatives coming from all over Greece attended the conference and
participated in the afternoon workshop.
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 2/11
The conference’s webpage had 6.000 visits (10/11-30/12/2013) while 115 people registered in
advance.
There were articles in the press leading up to the conference as well as a detailed report of the
work of the conference on the same day published by one of Greece’s largest news portals
( www.news247 .gr ). An article also appeared in one of the country’s largest dailies “Efimerida ton
syntakton” on Monday 16 December 2013 (47.000 followers on FB). Overall, the event received
considerable publicity despite the fact that on the same day, there was a major high-level
conference organized in Athens by the Greek Ministry of Health in cooperation with the WHO and
the European Commission’s Task Force (TFGR) on the heath reforms in Greece.
The event was webstreamed live. Intensive live tweeting took place the days before and on the
day of the conference (twitter analy tics ).
Our save the date/invitation was widely circulated by the office of MEP Nikos Chrysogelos
(Greens/EFA, EL), Médecins Sans Frontières (MSF), Médecins du Monde (MdM Greece), PRAKSIS
NGO, Greece’s leading consumer association and TACD member EKPIZO (it was sent to its 23.000
members across the country) as well as by the Greek cancer patients’ association DEDIDIKA. In
addition to the above, it was published in numerous news & medical websites (see indicative list
below).
Health Daily (the country’s largest daily health newsletter reaching 7.000 professionals – the
invitation & press releases were published 3 times leading up to the conference)
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 3/11
http://health.in.gr/news/various/article/?aid=1231279732
http://www.ygeia360.gr/el/news/item/8050-synedrio-gia-thn-prosbash-twn-ellhnwn-
asthenwn-sto-farmako
http://health.in.gr/news/various/article/?aid=1231279732
http://www.infospoudes.gr/index.php?
option=com_content&view=article&id=16816&catid=25028&Itemid=1209
http://www.almazois .gr/gr/index.php?option=ozo_content&perform=view&id=505
http://www.almazoispatras.gr/2%CE%BF-
%CE%B4%CE%B9%CE%B5%CE%B8%CE%BD%CE%AD%CF%82-
%CF%83%CF%85%CE%BD%CE%AD%CE%B4%CF%81%CE%B9%CE%BF-%CE%BF%CE%B9-
%CF%83%CF%85%CE%BD%CE%AD%CF%80%CE%B5%CE%B9%CE%B5%CF%82-
%CF%84%CE%B7%CF%82-%CE%BA/
http://www.mednet.gr/app/index.php/thenews/view/48
http://www.newmoney.gr/article/32350/synedrio-gia-tis-synepeies-tis-krisis-stin-prosvasi-
sta-farmaka
http://www.blog.gr/articles/168584/Diethnes-sunedrio-kai-seminario-me-ton-titlo-Oi-
sunepeies-tis-krisis-stin-prosbasi-sta-farmaka-H-koinonia-apaitei-dikaies-luseis.html
http://pharmateam.blogspot.gr/2013/12/blog-post_9125.html#axzz2oIT0z87c
http://www.life2day.gr/2013/12/sinedrioi-sinepies-tis-krisis-stin-prosvasi-sta-farmaka-h-
kinonia-apeti-dikees-lisis/
http://pefni.wordpress.com/2013/12/04/%CE%BF%CE%B9-
%CF%83%CF%85%CE%BD%CE%AD%CF%80%CE%B5%CE%B9%CE%B5%CF%82-
%CF%84%CE%B7%CF%82-%CE%BA%CF%81%CE%AF%CF%83%CE%B7%CF%82-
%CF%83%CF%84%CE%B7-
%CF%80%CF%81%CF%8C%CF%83%CE%B2%CE%B1%CF%83%CE%B7-%CF%83/
Synopsis of presentations’ main points
Welcome remarks
In his opening remarks, MEP Nikos Chrysogelos (Greens/EFA, EL) spoke of the need to have a
universal health coverage system in place. He emphasized the role of prevention as it reduces the
future cost of treatment. He underlined the fact that there are many cases reported in Greece of
people whose health has deteriorated considerably due to the fact that they either a) cannot afford
to take their treatments properly or b) they do not have access to primary health care.
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 4/11
David Hammerstein, Senior advocate, TransAtlantic Consumer Dialogue, Brussels He
highlighted the importance of the Greek Presidency of the Council of the European Union (first half of
2014). He referred to the budget reduction measures put forth by the European Commission for which
there are no evaluation-impact studies. He described fight against corruption and transparency as
key elements in dealing with medicines in Greece. Last but not least, he underlined the lack of
concrete data regarding various dimensions of the health crisis in the country.
Eleni Alevritou, President of EKPIZO stressed the importance of collective action in times of crisis.
She described the Greek civil society movement as a weak and disorganized one which nevertheless
needs to better organize itself in order to become more efficient.
Policy-making session I: The situation on the ground in Greece concerning access to life-saving
medicines moderated by David Hammerstein, Senior advocate, TransAtlantic Consumer Dialogue,
Brussels
Dr. Kostas Athanassakis, Research Fellow, National School of Public Health (ESDY) gave an
overview of the agreements between the Greek government and the Troika over the past years. He
started by saying that public pharmaceutical spending will be reduced to 2bn euro in 2014 i.e. a 60%
reduction in comparison to the 5bn euro spent in 2009. He then presented the basic reforms
concerning medicines in Greece namely the active ingredient-based prescription and the prices of
reference for the national insurance organization EOPYY. He explained that if the 2bn euro threshold
is not respected, the agreements foresee additional measures such as increasing co-payment
percentages as well as moving more medicines to the “negative list” i.e. list of medicines which are
not reimbursed. According to the latest agreements between the Troika and Greece, generics will
need to cover 60% in pharmacies’ sales and 50% of the use in hospitals. Moreover, he referred to all
of the mistakes made in the operation of EOPYY which have resulted among others in many people
losing their social coverage over the past three years. According to Dr. Athanassakis hospitals have
become the primary focus of the reforms along with the future role of EOPYY. Since the start of the
agreements, cutting pharmaceutical spending has been the top priority. This was to be achieved by
a) slashing the prices of medicines, thus reducing the profits for suppliers and b) cost-sharing thus
making things worse for patients. He commented that the cost-sharing tool is very common, can be
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 5/11
efficient in reducing pharmaceutical spending (average co-payment in Greece before 2009 = 9%,
today around 23%) but can also be extremely dangerous for health, as patients decide to forego
certain types of medicines which leads to immediate worsening of their health status. Furthermore,
deteriorating health conditions increase the cost of future treatment while chronic diseases become
lethal as regimens are not taken properly. He concluded by saying that reforms introduced so far
serve almost exclusively the goal of saving money today which will end up costing more tomorrow.
Prof. Christos Lionis, Director, Clinical Social and Family Medicine, faculty of Medicine & the
University Hospital of Heraklion (Crete) spoke of primary health care in Greece, a highly
controversial issue in the country since the government is in the process of introducing reforms in
this field too. He presented the data collected at the first primary care unit in the city of Heraklion
run by the University. This unit has been providing healthcare services to people with no insurance,
low income as well as migrants. He analyzed the profiles of patients visiting the unit concluding that
most of them are uninsured for over two years, they do not take their medicines as they are
supposed to either because their medicines are not available or they cannot afford them. He
emphasized that medical schools curricula need to change, become socially accountable and to
engage patients and other stakeholders.
Giorgos Zarkotos, President, Greek Association of Drugs and Substitutes Userscommented that
the crisis has deteriorated the problems that many marginalized social groups are faced with such as
prostitutes, substitute uses, prisoners, roma people, homeless, immigrants. He stated that most of
them apart from the social stigma have no access to health services. Moreover, state funding into
harm reduction programmes has been dramatically reduced. This has resulted in deteriorating health
situations such as a considerable increase in HIV cases in the country among drug users. Syringes
distribution has fallen to almost zero levels leading to this increase in HIV and Hepatitis C cases. He
emphasized that most Hepatitis C patients belonging to these social groups receive no treatment. He
called upon the Greek government to: a) support more needle and syringes programmes, b)
strengthen HIV testing and counseling, c) provide comprehensive and sustainable ART treatment, d)
focus on vaccination, diagnosis and treatment of viral hepatitis and e) reinforce prevention, diagnosis
and treatment of tuberculosis.
Liana Mailli, President, Médecins du Monde Greece presented valuable data from the MdM’s
activities on the ground. She said that more and more people visit the clinics & medical centres run
by MdM Greece in order to receive not only health services but also food and clothing. During the
first nine months of 2013, more than 13.000 people have used the mobile medical units of MdM
Greece. She emphasized that there is a 20% annual increase in the number of people using the
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 6/11
various services of MdM Greece. Vaccines constitute the number one type of medicine that people
who turn to MdM Greece ask for which demonstrates that children are also very much affected by
the austerity crisis. In the first nine months of 2013, around 7.000 children were vaccinated. She
added that more than 2.500 people visit the main MdM clinic in Athens on a monthly basis. Most
people using MdM services are Greeks who have fallen off the social safety net. This means that
these people and their families do not have access to any health services anymore.
Policy-making session II: Benchmarks ahead moderated by Tassos Telloglou, Reporter,
Kathimerini newspaper & Star Channel
Rohit Malpani, Director, Policy and advocacy, Doctors Without Borders’ Access
Campaign explained that patent monopolies lead to extreme prices for life-saving treatments. He
gave the example of the recently approved Hepatitis Cdrug which will be sold at 60.000 euro for a
12-week course even though the cost of manufacturing it ranges between 50-100 euro. He criticized
the view that tiered-pricing is the way forward stating that price reductions are not always
sufficient, it is usually implemented in an arbitrary manner and all of the above; usually unfold in
complete lack of transparency. In relation to the issue of patents, he stated that these should only
be granted for true innovations and ever-greening should be avoided. In this respect, he mentioned
that a generic equivalent of the famous cancer drug Herceptin was recently approved in India. He
stressed that most innovation stems from publicly-funded research which should not be given as a
present to pharmaceutical industries. In addition to the above, he criticized the European Commission
for exercising pressure on developing countries that employ compulsory licensing and other
safeguards to ensure affordable treatment. In his view, the European Commission should refrain from
supporting tiered pricing as the solution to access. Moreover, he expressed the view that free trade
agreements should not limit the ability of EU Member States to use public health safeguards. Last but
not least, he reminded everyone that anti-competitive intellectual property strategies cost EU
consumers 2 billion Euros between 2000 and 2007.
Dr. Christos Ntellos, Director, Cardiac surgical dept. Tzanio public hospital (Pireaus) stated
that doctors overprescribe medicines in Greece. He stressed that innovative medicines which are
highly promoted by the pharmaceutical industry are not truly innovative while they cost a fortune for
the national health budget. He criticized the role of doctors in joining those glorifying innovative
medicines even though they know very well that there is no substantial difference. To this end, he
gave the example of medicines against cholesterol which are profusely prescribed even though it is
clear that exercise is much more effective in the fight against cholesterol. This is why; there is still a
lot of space for corruption. He called on doctors to stop playing with patients’ sense of agony and
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 7/11
hope when it comes to generics and new innovative medicines. In his view, reliable generics are the
way forward. He commented that people need to realize that expensive medicines do not necessarily
equal better treatments. He concluded by pointing out the following: a) patients’ real needs in
medicines are much smaller than the medicines prescribed and consumed today, b) there need to be
strict therapeutic protocols in place, c) priority should be given to the use of generics and d) older
and cheaper medicines should not be sidelined.
Prof. Nikos Maniadakis, Associate Dean, National School of Public Health (ESDY) author the
latest pricing law on medicines gave an in-depth presentation of the piece of legislation. He analyzed
the spectrum of measures implemented by the Greek government in relation to medicines in Greece
(new lists of medicines, strict budget thresholds, new pricing scheme, e-prescription, generics,
guidelines and therapeutic protocols). In terms of patent medicines, their price will be defined
according to the three lowest prices in EU member states. As regards, off patent medicines, their
price will be halved following the expiry of the patent. As for generics, their price will be further
reduced and will be determined at 65% of the off patent medicine with a similar active ingredient. He
added that the law anticipates the possibility for some dynamic pricing i.e. the higher the sales of a
generic medicine are, the cheaper they can get. Editor’s note: This is considered by Greek pharma as
the most threatening provision. In their view, dynamic pricing is the Ministry’s present to foreign
pharma as it will enable the latter to lower their generics’ prices tremendously and consequently wipe
Greek companies off the map.
Giulia Del Brenna, Adviser, Task Force for Greece, European Commissionthanked the NGO
community for providing data on the real situation in Greece while she criticized the Greek
Government for not giving any reliable data on health coverage and access to medicines.
Sheexplained that the work of the Task Force is to ensure universal health coverage through a social
safety net with the use of clinical guidelines and protocols. She stressed that what is needed in
Greece is transparency. She highlighted the importance of primary health care reform. She reiterated
that it is up to the Greek government to decide which measures to implement in putting the reforms
in place. She acknowledged that “in an ideal world” there should have been impact assessment
studies of the reforms put forth. E-Health constitutes one of the main focal points of the technical
assistance when it comes to hospital management.
Charalambos Karathanos, Pharmacist, Advisor to the Minister of Health on medicines
issues clearly stated that the 2bn euro target for 2014 is neither feasible nor realistic. He repeated
the government’s position that 2.5 bn euro will be needed for 2014 and reiterated that the final figure
is still under negotiation with the Troika. He reaffirmed the government’s determination to encourage
the use of generics in the Greek NHS and criticized those who question the safety and quality of
generics. He reminded everyone that most generics used in Greece come from Greek pharmaceuticals
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 8/11
that produce excellent quality products. On the issue of the uninsured people living in Greece, he
stated that the government is seeking to find solutions. Last but not least, he referred to the
presentation of Oliver Moldenhauer (TACD event in Athens, 31 May 2013) regarding the prospect of
using WTO provisions and flexibilities in order to allow for cheaper medicines to enter the Greek
market.
The Q&A session that followed was dominated by questions addressed to the TFGR representative
and the Minister’s advisor. Discussion was very much heated between the Minister’s advisor and
patients’ representatives.
Civil society empowerment workshop/advocacy capacity-building
(about 40 patient representatives coming from all over Greece)
Session 1: Towards an effective patients’ movement in Greece
Alex Wyke, Patient View, founder and Managing Director explained the reasons why policy-
makers need to listen to patient groups: a) Health costs are governed by the demands that patients
place on the national healthcare system, b) Such systems need to spend wisely—but also to
understand patients (and thereby not waste resources on unnecessary services) and c) Patient
groups understand patients. They can support patient empowerment, and help make the best use of
resources outside healthcare systems. She added that patients can play a crucial role in the
following areas: a) influencing the doctors’ environment, b) lobbying for budget, c) helping to set
prescribing guidelines, d) shaping government priorities and e) defining professional accountability.
There are numerous sources of information for patients; all they have to do is know where to look. In
addressing the Greek patients associations, she emphasized that fragmentation is their biggest
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 9/11
challenge and enemy. Policymakers have little time, and do not want to speak to hundreds of patient
groups. They also believe that disease-oriented patient groups have vested interests, and are
prejudiced. Last but not least, fragmented patient groups are not as effective as networked patient
groups that present a unified image. She gave the example of cancer patients where PatientView has
identified 50 different types of patient groups which tend to act independently of one another.
Nevertheless, she commented that an ever-closer integration process is unravelling while cross-stake
holder coalitions are now increasingly happening.
Kathi Apostolidis, President, DE.DI.DI.KA. & Vice-president, European Cancer Patients
Coalition (ECPC) guided the audience through the social media world and its use today. In her view,
patient groups need to take advantage of the potential that social media has to offer. She stressed
that efficient social media use requires commitment, time and money as it usually takes a staff
member working exclusively on setting up and most importantly, sustaining in the long term an
organization’s social media platforms. These means can be used among others to raise public
awareness, attract attention and publicity, raise funds and recruit new members. For example, social
media platforms could be employed to recruit some additional volunteers in light of an event that the
organization is planning to host or to build new relationships with influential figures who can act as
multipliers for the organisation’s messages. She mentioned the following rules regarding the use of
social media: 1) Listen. Social Media is not about you. It is about people’s relationships with you.
Listen before you speak. 2) Get involved. Social Media is about conversations and building
relationships. It takes effort. 3) Don’t just talk about yourself. Ask questions, engage people and link.
Most of all be inspiring. 4) Give up control. You cannot control the conversation. If you want people
to spread your message, you have to trust them. 5) Be honest. You can’t spin the truth with Social
Media. Be open, honest and authentic in everything you say and do.
Following the two presentations, patient representatives were split into two working groups of about
15 people and were called upon to brainstorm on one question each. Working Group A was instructed
by Alex Wyke to present the main priorities of the patients’ movement in Greece while Kathi
Apostolidis instructed Working Group B to work on a social media strategy for their respective
organisations.
Debate in Working Group A was rather heated as participants found it difficult a) to comprehend
what was asked of them, b) to think beyond the narrow limits of their own organization and c) agree
on common priorities of mutual concern and interest. Nevertheless, they listed the following as
overarching priorities for all patients in Greece:
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 10/11
1 . Universal public health coverage in Greece with special attention to chronic diseases
2. Access to health services irrespective of one’s employment status for everyone living in the country
3. Patient empowerment
4. Training of patients so as to be able to better participate and engage
5. Raising public awareness – prevention – diagnostics
6. Transparency at all levels when it comes to medicines a) safety & quality (cost-benefit analysis &
efficacy) and b) affordability (both for the patient as well as the state budget)
7 . Affordable medicines & treatments
8. Right to work for handicapped people & people with chronic diseases
Session 2: “Weapons” of the patients’ movement in times of crisis
Gaelle Krikorian, Adviser on Intellectual Property & Access to Knowledge-Greens/EFA,
European Parliament spoke about the special features of the following semester for Greece having
the EU presidency in combination with the European elections in May. She expressed the view that
people have a say in EU affairs through parliamentary questions, questions addressed to the
European Commission, the citizens’ initiative as well as the Troika enquiry. Therefore, she called on
participants to elect good parliamentarians next May. She then commented that expensive medicines
can be dealt with through good quality generics which nevertheless, do not solve the issue of patent
monopolies and outrageous medicines’ prices. She explained that it is a very sensitive subject which
when implemented causes a series of retaliations from both governments and the pharmaceutical
industry. She nonetheless explained that it is a goal worth pursuing as Thailand did. Thailand took
the political decision to issue a compulsory-license on heart, HIV and cancer medicines. Strong social
mobilization on behalf of patient groups, NGOs working on public health, academics and other civil
society stakeholders rallied behind the Thai government’s decision. Workshop participants were
encouraged to examine compulsory-licensing in the case of Greece.
2/7/2014 IP Policy Committee blog » Blog Archive » Event summary: Greek Society demands fair access to medicine solutions
http://tacd-ip.org/archives/1127#! 11/11
Maria Moudatsou, Forensic Psychologist, Director of Institutional & Vertical Fundraising, NGO
PRAKSIS guided patient groups through the process of fundraising. She explained everything ranging
from where to look for grants and funding opportunities, how to approach sponsoring entities such as
foundations, organizations and others, how to present an organization, how to apply for a grant etc.
She emphasized the need for synergies and forging alliances with other stakeholders. Strategic
planning & management constitute another pillar for the organization of a patient group.
Dimitris Kremalis, Partner, Kremalis Law Firm & President, Greek Health Law
Association provided a brief overview of the legal framework for patients in times of crisis
[Seminar report] Tackling Health Inequalities throughInvesting in Housing
Conference on 22 January in the European Parliament (Brx) organised by EPHA &CECODHAS Housing Europe, and hosted by the EP Urban Intergroup
The event ’Tackling Health Inequalit ies through Investing in Housing’ focused on theconnection between health inequalit ies and affordable housing. It emphasised thatinvestment in good quality housing can bring returns in health and environmentaloutcomes.
Evidence shows that decent housing is an important social and environmental determinantof health [1] These determinants lie outside of the health sector [2]. Nevertheless, neitherhealth professionals nor health policymakers are able to tackle health inequalit ies in the housingsector without the support and cooperation of their colleagues in the fields of housing. This madethe case for a joint seminar between the European Public Health Alliance, the Federationof public, cooperative and social housing and the European Parliament Urban Intergroup.
The Agenda of the event is available here.
MEP Karima Delli, vice-president of the EP Urban intergroup who hosted the event,deplored the fact that the link between housing and health is all too often overlooked at aEuropean level. She highlighted that EU member states are seeking to reform their welfare statesunder serious budget constraints, acknowledging that a more nuanced awareness of theintricacies between health and housing is necessary to promote more efficient spending in
Related documents
One millionsignatures for Wateras a Human Right!
EPHA service
EPHA contribution tothe Commisisonconsultation onUrban Mobility
About us
Library and MediaCentre
A↑
A↓
FollowFollow 1,870 followers
Newsletter
RSS
Members only
search >>
PDFmyURL.com
social and care services.
Karima Delli is the rapporteur of the EP own init iat ive report on Social housing in the EuropeanUnion
CECODHAS Vice-President Özgür Öner stated that “investment in social infrastructurestoday will relieve public budgets for health and social assistance in the longer run”.
EPHA Secretary General Monika Kosińska said that “improving housing for workers wasone of public health’s first areas at its birth. We need to rethink these synergies to ensure thatwe enjoy good quality public housing to reduce the impact of poverty and build healthypopulations and communities.“
Measuring the housing component of health inequalit ies in Europe Matthias Braubach, TechnicalOfficer of WHO Europe Environment and Health, coordinator of the WHO report onenvironmental health inequalities in Europe detailed the many housing-related environmentaldisadvantages that impact on people’s health: lack of flush toilets, shower or bath, dampdwellings, excessive exposure to noise, difficulty in accessing recreational or greenareas and thermal discomfort. [3]
Furthermore, high housing costs have indirect negative health outcomes as itdangerously limits families spending for other basic needs. According to a 2011 report [4],inadequate housing accounts for around 100 000 deaths per year in the WHO European region.
In all cases, poor households are more exposed to these disadvantages but dependingon the issue and the countries, it can be a more widespread problem (notably in new memberstates). Also worth underlining is the fact that housing-related inequalit ies areaccumulative and clustered. This means that populat ion groups that combine socio-economiccharacterist ics such as being low income, single parent families and/or large families haveincreased the chances to be exposed to housing-related environmental disadvantages and thatthey are often affected by several types of inequalit ies at the same t ime. the presentation of Matthias Braubach: Environmental Health Inequalit ies in Europe – Health and
Housing implications.
Carlotta Balestra, policy analyst in the Directorate of Statistics of the OECD , introduced theresults of an analysis by the OECD exploring the determinants of housing and neighbourhoodsatisfact ion among a series of micro-data?. She noted that people who assess their healthstatus as good, are much more likely to assess their housing situation assatisfactory.
There are great discrepancies across EU countries as regards child-injury risks,pointed out Morag MacKay from Childsafety Europe, who highlighted shortages in preventionpolicies concerning home safety of children. the presentation of Morag MacKay: Analysis of national policies to address injuries in the built
environment of the home
Investing in human capital: housing is more than just a roof!
Centre
EPHA consultancy -Public relations,media and events:benefit from EPHAexpertise!
EPHA 4th AnnualConference. BraveNew World: 4-5September 2013
EPHA meeting roomfor rent
Thinking of joiningEPHA?
CreditsThe European PublicHealth Alliance runsprojects which receivefinancial support from theEuropean Commission.The views expressed inthis website do notnecessarily reflect theofficial views of the EUinstitutions.
This website is powered
PDFmyURL.com
With the presentation of the OECD Better Life Init iat ive, Carlotta Balestra stressed theimportance of thebeyond-GDP approach and she proposed to shift from “treasuring what youmeasure - the GDP - to measuring what you treasure”. The index compiles eleven indicators ofhuman well-being including housing and health and safety. Ms Balestra insisted that housing is notonly about sheltering from bad weather: quality housing increases people’s self-esteemand social capital. Having access to decent housing is at the basis of human dignity. She finallyunderlined that well-being is sustainable over t ime because it builds up human, natural,economic and social capital that feeds into tomorrow’s well-being. the presentation of Carlotta Balestra: OECD findings on health inequalit ies and housing
Efficient spending: invest in social infrastructure today to save money tomorrow
This vision is likely to be endorsed by the up-coming Social Investment Package of the EuropeanCommission, suggested Fritz von Nordheim, from DG Employment and Social Affairs . Europeneeds to put an end to the destruction of human capital triggered by today’s soaringunemployment levels. More emphasis should be put on social investment because thequality of our labour force depends on the support we provide to people throughout their life. M.von Nordheim also recalled that the earlier you invest in somebody’s life, the higher the returns interms of reduction of inequalit ies and increases in their capacit ies.
Drawing from the example of social housing in Northern Ireland, Joe Frey, Head of Research at theNorthern Ireland Housing Executive, explained that if investment in energy efficiency of buildingshad failed to take place in the past years, fuel poverty would have gone up by 50%. He alsopresented the results of a study undertaken by the Building Research Establishment: investmentsof nearly € 600 million to reduce category 1 hazards in the housing stock in the UK would cutdown health expenditure by € 40 million per annum and thus have a payback period of 13 years. the presentation of Joe Frey: Health benefits of investing in housing and impact on health
expenditure/ Fuel poverty and health impacts
Capitalizing on synergies to improve service coverage and social integration
Dr Chris Handy, CEO of the Accord Group , advocated for a renewed partnership betweensocial housing providers and healthcare services. The Accord Housing Group endeavoursto open up new horizons with init iat ives such as Direct Health, where Accord Group acquired anindependent healthcare company in order to increase home care and residential support providedto tenants. the presentation of Dr Chris Handy: Cooperation between social housing organisations and
health services providers
Undertaking combined health-housing action proves very efficient when it comesto targeting marginalised communities. Deyan Kolev, from the NGO Amalipe pointed tosome de-segregating projects for the Roma in Bulgaria that involved integrated approaches -notably with housing and health dimensions - with support from EU funds. According to Kolev,these are pilot models that should be implemented on a national basis. the presentation of Deyan Kolev: Social housing sector inclusive towards marginalized
communit ies
This website is poweredby open sourcesolutions and runs on aLinux server.
PDFmyURL.com
Natalia Rogaczewska from the BL housing associat ion explained how a Danish non-profithousing organization trains voluntary tenants to become Health Ambassadors and run seminarsamong tenants to promote healthy eating regimes and lifestyle. the presentation of Natalia Rogaczewska: Educating tenants for a healthy lifestyle
Finally, Dr Pascale Estecahandy, National Technical Coordinator of the "Un chez soi d’abord"programme, submitted encouraging results from a French experimental programme forreintegration of homeless people based on the “housing first” model. the presentation of Dr Pascale Estecahandy: Social housing sector, homeless population and
health outcomes
Recommendations for further action:
Rethink the relationship between end users and service providers According to Claire Roumetchanges come from the ground. The policies that work are the ones that take people and makethem act. Therefore public services should not be a place where people go but public servicesshould connect with each other and reach out to the people.Reconsider social spending as an investment for future human capital. The crisis is too oftenused as a false excuse to mit igate what can be done in part icular for marginalised groups likeRoma people, in the opinion of Michel Verschraegen from DG Justice. Member states needto continue to spend on social issues and budgetary adjustments should be implemented afterconsult ing with relevant stakeholders so as not to put social services in jeopardy.Combine general and targeted action to improve living conditions for all. More efforts can bemade to ensure affordable and quality housing for all as well as to reduce fuel poverty. Measuresto increase energy efficiency of buildings will be vital in the context of rising energy prices anddecreasing disposable income. Although this has been identified as a fundamental investmenteffort, inadequate ventilat ion has important negative health outcomes and should not bedisregarded.Continue research and collect more data in order to better identify the most vulnerablegroups.Both WHO and OECD plan to collect and harmonize more data about housing condit ionsand affordability. In the field of fuel poverty, trying to define vulnerable energy consumers needsto go further than the income element, contended Kyriakos Gialoglou, from DG Health andConsumers. Vulnerability has to do with situations that potentially concern everybody. A reportfrom the Vulnerable Consumers Working Group is expected by the end of 2013. the presentation of Kyriakos Gialoglou: Actions against energy vulnerability & towards delivering
warmer & healthier homes for European consumersIntegrating approaches and better coordination of initiatives were two points that wererepeatedly called for by speakers, notably when it comes to init iat ives funded by the EU. AndorUrmos from DG Regional and Urban Policy warned that for the next period 2014-2020, the EC willbe expecting more consistency between national policies and the operational programmes. the presentation of Wladyslaw Piskorz (presented by Andor Urmos): Inclusive Growth, Urban and
Territorial, DevelopmentAddressing homelessness by making accessible advice centres, as well as counselling andrehabilitation programmes Homelesses is the extreme form of deprivation of housing. Bypresenting the different element of the Social Investment Package, Fritz von Nordheim from
PDFmyURL.com
DG EMPL highlighted the importance of investing in social infrastructure, as well.
Open discussion with the participations of MEPs.
At the end of the event, a roundtable discussion was held by the active part icipation of severalMEPs (Alejandro Cercas (Spain, S&D) MEP and shadow rapporteur of the EP report on socialhousing, Jean Lambert MEP (UK, Greens/EFA), Françoise Castex MEP (France, S&D) during whichpart icipants discussed the following issues:
Could and should the EU do more for a quality housing sector supporting health equity? Whatcould be done, when, by whom and to what end?
What do we need to make it happen? Research, funds, collaboration, political will, socialmovement, leadership?
How can the European elections 2014 help change the paradigm of social investment?
The main messages of MEPs are quoted in the EPHA-CECODHAS Housing Europe Jointpress statement "Fighting an uneven battle - without tackling poor housing, the race againstsocial exclusion risks stumbling", which is available on request.
on EPHA website on CECODHAS Housing Europe website
Related EPHA articles
[Seminar] Tackling Health Inequalit ies through Investing in Housing Energy and Health: How are these Policies Connected? Why should we Tackle Energy Poverty? European Urban Health Conference - Amsterdam, September 12th-14th 2012 The Impact of the Economic Downturn and Policy Changes on Health Inequalit ies - the example
of London Poverty is Not a Crime! - European campaign against the criminalisat ion of homelessness and
poverty kicks off in Brussels Most EU Member States Fail to Ensure the Right to Housing - FEANTSA Press Release
PDFmyURL.com
Other articles you might find interestingabout environment
Footnotes
[1] Social and environmental determinants of health are the condit ions in which people are born,grow up in, live, work and age. They have impacts on the opportunit ies people have to havehealthy lives; affect the chances of developing illness and suffering injury; and also impact onpeople’s life expectancy.
[2] WHO Commission on Social Determinants of Health (2008) Closing the gap in a generation:Health equity through an action on the social determinants of health. Final Report. Geneva: WorldHealth Organisation
[3] Findings from the WHO report Environmental Health Inequalit ies in Europe, 2012.
[4] WHO report Environmental burden of disease associated with inadequate housing. Methodsfor quantifying health impacts of selected housing risks in the WHO European Region, 2011.
Last modified on February 5 2013.
PDFmyURL.com
European Parliament puts spotlight on the importance of social housing in the EU[Save the date] CECODHAS Housing Europe colloquium on the question “Where is housing inthe future social contract?”
about EU Institut ions[Water is a Human Right campaign] First ever European Cit izens Init iat ive to make it !European Year for Cit izens - moving to a Union for Cit izens
about Civil SocietyHow to reinforce the social dimension of the EU under the Lithuanian Presidency?[EPHA Call to Action] Health in the reform of economic governance
about Social IssuesThe European Year of Cit izens Alliance (EYCA)[eHealth week] eHealth innovation must be driven by full inclusion
about children and adolescents[EPHA media reaction] Ireland’s move to implement tobacco plain packaging must resonatein Brussels[EPHA posit ion paper] Revision of the Tobacco Products Direct ive
about poverty and healthMEPs’ reject ion of cuts for EU’s Fund for Most Deprived should be followed by more healthyand nutrit ious food provisionJoin proposal to support Recommendations on Child Poverty & Well-being
about equity[Roundtable] Commissioner Reding and Andor on Roma rightsFundamental Rights to Promote Public Health
about Health Inequalit iesSpirometry day - EU Commissioner for health supports lung test ing66th World Health Assembly approves Mental Health Action Plan 2013-2020
about vulnerable groups[Save the date] EPHA 4th Annual Conference 4-5 September 2013, Brussels[European Observatory] Venice Summer School 2013
about housingChildren’s well-being: investing in a healthy future - a silent emergency in Europe[Save the date] FEANTSA Seminar - Housing Rights in Hungary
about energyAddressing fuel poverty in deprived urban areas
PDFmyURL.com
[Seminar] Tackling Health Inequalit ies through Investing in Housing
about exclusionEuropean Year of Cit izens: Are Roma people European cit izens like any others?UNICEF Innocenti Report Card: Child Well-being in Rich Countries.
about prevention[HEAL report] In Poland, health cost associated with air pollut ion from coal power generationaccounts to 3-8.2 bn euro every yearCall for an EU Strategy and Action Plan on HIV/AIDS after 2013
about European Parliament[Event digest] Calling Time on Europe’s Alcohol Problem - Using pricing policies to protectpublic health in EuropeNanomaterials in plast ic packaging - are they safe for consumers?
about European CommissionInvolvement of civil society organisations crucial to effect ively run EU funds, says EU-CommissionConsultat ion for the review of the European policy on organic agriculture
about social inclusionEPHA briefing: Health in the Europe 2020 Strategy[Public Statement] International Romani Day - the curse of being Roma in Europe and gett ingproper healthcare
about RomaBreaking barriers - Roma students can become doctors!Poverty and inequality in societ ies of human rights - the paradox of democracies
about discriminationAmnesty International urges EU Institut ions to end Female Genital Mutilat ion[Seminar invitat ion] Health in t imes of transit ion in nine former Soviet countries (12 March,Brussels)
about social determinants of healthClock is t icking in the run up to historic CAP reform deal[Pre-announcement] Violence Against Children Report Cards to be launched
about social protectionHealth systems in t imes of global economic crisis: an update of the situation in the WHOEuropean Region[Médecins du monde] Access to healthcare in Europe in t imes of crisis and rising xenophobia
PDFmyURL.com
about Fundamental Rights[EPHA’s 20th anniversary series] There is no t ime like the presentEuropean Parliament’s Legal Affairs Committee adopts opinion on General Data ProtectionRegulation (GDPR)
0
European Public Health Alliance - Rue de Trèves 49-51 Box 6, B-1040 Brussels, Belgium . phone: +32 2 230 3056 - f ax: +32 2 233 3880 [email protected]
PDFmyURL.com